Showing results 32 to 39 of 39
< previous
| Issue Date | Title | Author(s) |
| 2024-04 | Revolutionising Lung Health: Exploring the Latest Breakthroughs and Future Prospects of Synbiotic Nanostructures in Lung Diseases | Saeid, AB; De Rubis, G; Williams, KA; Yeung, S; Chellappan, DK; Singh, SK; Gupta, G; Hansbro, PM; Shahbazi, M-A; Gulati, M; Kaur, IP; Santos, HA; Paudel, KR; Dua, K |
| 2023-12 | Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma | De Rubis, G; Paudel, KR; Yeung, S; Agarwal, V; Hansbro, PM; Oliver, BGG; Dua, K |
| 2022-10 | Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases | Ashique, S; De Rubis, G; Sirohi, E; Mishra, N; Rihan, M; Garg, A; Reyes, R-J; Manandhar, B; Bhatt, S; Jha, NK; Singh, TG; Gupta, G; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Oliver, BG; Dua, K |
| 2023-03 | Tackling the cytokine storm using advanced drug delivery in allergic airway disease | Patel, VK; Vishwas, S; Kumar, R; De Rubis, G; Shukla, SD; Paudel, KR; Manandhar, B; Singh, TG; Chellappan, DK; Gulati, M; Kaur, IP; Allam, VSRR; Hansbro, PM; Oliver, BG; MacLoughlin, R; Singh, SK; Dua, K |
| 2024-02 | The application of nanoparticles as advanced drug delivery systems in Attenuating COPD | Jessamine, V; Mehndiratta, S; De Rubis, G; Paudel, KR; Shetty, S; Suares, D; Chellappan, DK; Oliver, BG; Hansbro, PM; Dua, K |
| 2023-02-06 | The versatility of 18β-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders | Mohamad, MSB; Reyes, R-J; De Rubis, G; Paudel, KR; Hansbro, P; Dua, K; Chellappan, DK |
| - | Zerumbone liquid crystalline nanoparticles protect against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro | Paudel, KR; Clarence, DD; Panth, N; Manandhar, B; De Rubis, G; Devkota, HP; Gupta, G; Zacconi, FC; Williams, KA; Pont, LG; Singh, SK; Warkiani, ME; Adams, J; MacLoughlin, R; Oliver, BG; Chellappan, DK; Hansbro, PM; Dua, K |
| - | Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro | Manandhar, B; Paudel, KR; Clarence, DD; De Rubis, G; Madheswaran, T; Panneerselvam, J; Zacconi, FC; Williams, KA; Pont, LG; Warkiani, ME; MacLoughlin, R; Oliver, BG; Gupta, G; Singh, SK; Chellappan, DK; Hansbro, PM; Dua, K |
